Decibel Cannabis Company Inc. (DB.V)
| Previous Close | 0.1700 |
| Open | 0.1650 |
| Bid | 0.1650 x N/A |
| Ask | 0.1700 x N/A |
| Day's Range | 0.1650 - 0.1650 |
| 52 Week Range | 0.0650 - 0.1850 |
| Volume | |
| Avg. Volume | 179,670 |
| Market Cap | 67.122M |
| Beta (5Y Monthly) | 1.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | Nov 13, 2023 - Nov 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.40 |
CNW GroupDecibel Confirms Resignation of Director
Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), today announced that it has accepted the resignation of Paul Wilson in respect of his position as a director of the Company.
CNW GroupDecibel Engages ICP Securities Inc. as its Market Maker and Global One Media's Social Media Services
Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide market-making services, with the objectives of correcting temporary imbalances in the supply and demand for, and improving the liquidity of, the Company's common shares. Decibel is equally as pleased to announce it has engaged the services of Gl
CNW GroupDecibel Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C LABS for Distribution in the United Kingdom
Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has expanded its global footprint by entering into a supply agreement (the "Agreement") to provide premium dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicin
